Diabetic Retinopathy: Peripheral Surveillance

OPTOS UWF imaging identifies peripheral nonperfusion and neovascularization in diabetic patients. A 2015 study found 19% of eyes were graded as more severe using UWF imaging, directly impacting treatment plans.2 Early detection of ischemic areas facilitates targeted laser therapy in diabetic retinopathy .3

Retinal Detachments: Preventing Vision Loss Through Early Detection

UWF imaging captures peripheral breaks and subclinical detachments often overlooked in dilated exams. In retinal tears or detachments, OPTOS visualizes vitreoretinal traction and subretinal fluid extent, guiding surgical planning.3 For exudative detachments secondary to inflammation or tumors, FAF differentiates active lesions from chronic scarring.4

Age-Related Macular Degeneration: Tracking Metabolic Decline

FAF highlights metabolic stress in retinal pigment epithelium (RPE), revealing geographic atrophy progression in AMD years before symptoms onset.2 FAF-defined lesion growth rates predict rate of vision decline, informing lifestyle and treatment decisions.

Uveitis and Inflammatory Conditions: Mapping Disease Activity

Posterior uveitis often manifests with peripheral vasculitis and retinal snowbanking—lesions optimally visualized via UWF imaging. FAF hyperautoflorescence indicates active inflammation (ie. uveitis ), while hypoautofluorescence signal RPE atrophy, guiding prognosis and management plan.5

Retina Archives | North Toronto Eye Care

Technology Spotlight: OPTOS Imaging in Modern Retinal Care

Eye Exam,Eye Health,Featured,Retina,What's New

North Toronto Eye Care incorporates cutting-edge diagnostic tools that exceed standard OHIP-covered services. OPTOS multi-modal technology uses ultra-widefield imaging (UWF) and Fundus Autofluorescence (FAF) that provides eye care specialists with unmatched retinal visibility, enabling early intervention for diseases like diabetic retinopathy, age-related macular degeneration (AMD), and retinal tears.1 OPTOS utilizes scanning laser ophthalmoscopy to capture…

Understanding Ozempic’s Impact on Diabetic Eye Health: Guide for Patients

Cataract,Eye Exam,Eye Health,Featured,Medical News,Retina

Ozempic (semaglutide) is a medication used to help manage type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists, which help lower blood sugar by increasing insulin release, decreasing glucagon secretion, and slowing gastric emptying.1,2 It has revolutionized diabetes management, but its ocular effects require careful consideration – especially for patients…

Flat lay of diabetes management tools with blue ribbon symbolizing awareness on a light blue background.